Position in PHVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$92,519,101
+$16,935,972 QoQ
Shares Held
2,675,509
0.0% QoQ
Ownership
3.81%
of shares outstanding
% of Portfolio
5.50%
of 13F equity value
Holder Rank
#8
of 125 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PHVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bain Capital Life Sciences Investors, LLC holds $1,318,022,438 across 17 Biotechnology names. PHVS ranks #5 (7.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KLRA |
Kailera Therapeutics, Inc.
|
22,583,268 | $497,509,394 | |
| 2 | NAMS |
NewAmsterdam Pharma Co N.V.
|
3,906,565 | $131,141,499 | |
| 3 | SVRA |
Savara Inc
|
17,600,621 | $108,419,825 | |
| 4 | SLDB |
Solid Biosciences Inc.
|
9,808,819 | $97,990,101 | |
| 5 | PHVS |
Pharvaris N.V.
This page
|
2,675,509 | $92,519,101 | |
| 6 | OLMA |
Olema Pharmaceuticals, Inc.
|
7,085,249 | $88,636,464 | |
| 7 | COAG |
Hemab Therapeutics Holdings, Inc.
|
1,650,000 | $60,604,500 | |
| 8 | CABA |
Cabaletta Bio, Inc.
|
17,241,445 | $53,620,893 |
All Filings in PHVS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $92,519,101 | 2,675,509 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $75,583,129 | 2,675,509 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $77,757,747 | 2,802,081 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $79,372,811 | 3,181,275 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $58,139,505 | 3,303,381 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $51,863,081 | 3,303,381 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $63,325,813 | 3,303,381 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $61,178,616 | 3,303,381 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $62,103,562 | 3,303,381 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $76,341,134 | 3,303,381 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $109,516,147 | 3,904,319 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $99,856,146 | 4,784,674 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $73,713,389 | 4,868,784 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $25,619,741 | 3,180,601 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $35,781,761 | 3,180,601 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $24,395,209 | 3,180,601 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $70,291,282 | 3,180,601 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $57,680,199 | 3,180,601 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $45,768,848 | 3,180,601 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $56,392,055 | 3,180,601 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $59,254,596 | 3,180,601 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $88,993,215 | 3,180,601 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||